IP Library Granted Patent US 12,024,821
Granted Patent B2
US 12,024,821 · App. 17/407,297 · Granted Jul 2, 2024

Modified sulfuric acid and uses thereof

Inventors: Clay Purdy (Medicine Hat, CA); Markus Weissenberger (Calgary, CA); Markus Pagels (Calgary, CA); Kyle G Wynnyk (Calgary, CA)
Assignee: SIXRING INC.
D21C3/003D21C1/04D21C3/04D21C9/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,024,821
App. No.
17/407,297
Granted
Jul 2, 2024
Kind
B2
Abstract

An aqueous composition comprising: sulfuric acid; a heterocyclic compound; and a peroxide. Said composition being capable of delignifying biomass under milder conditions than conditions under which kraft pulping takes place.

Claims (17)

1. An aqueous acidic composition consisting of:

sulfuric acid;

a heterocyclic compound;

a peroxide; and

water,

wherein

the composition has a sulfuric acid to heterocyclic compound molar ratio ranging from 5:1 to 30:1, and

the composition has a sulfuric acid to peroxide molar ratio of 1:1.

2. The composition according to claim 1 , wherein the sulfuric acid to heterocyclic compound molar ratio ranges from 10:1 to 20:1.

3. The composition according to claim 1 , wherein the sulfuric acid to heterocyclic compound molar ratio ranges from 5:1 to 20:1.

4. The composition according to claim 1 , wherein the sulfuric acid to heterocyclic compound molar ratio is approximately 10:1.

5. The composition according to claim 1 , wherein the heterocyclic compound has a molecular weight below 300 g/mol.

6. The composition according to claim 1 , wherein the heterocyclic compound is a secondary amine.

7. The composition according to claim 1 , wherein the heterocyclic compound is selected from the group consisting of imidazole, N-alkylimidazole, N-methylimidazole, triazole, pyrrole, pyrazine, benzotriazole, quinoline and combinations thereof.

8. The composition according to claim 1 , wherein the heterocyclic compound is selected from the group consisting of imidazole and N-methylimidazole.

9. The composition according to claim 1 , wherein the heterocyclic compound is imidazole.

10. The composition according to claim 1 , wherein the peroxide is hydrogen peroxide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2023
From: PURDY, CLAY; WEISSENBERGER, MARKUS; PAGELS, MARKUS; WYNNYK, KYLE G.
To: SIXRING INC.
Reel/Frame 063276/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2023
From: PURDY, CLAY; WEISSENBERGER, MARKUS; PAGELS, MARKUS; WYNNYK, KYLE G.
To: SIXRING ING.
Reel/Frame 063176/0444 →
Priority Claims (1)
CA CA 3110357 · Feb 25, 2021 · national
Continuity (1)
Related Publication 20220267951A1 · Aug 25, 2022